Prostate Cancer may Precipitate the Risk of developing Serious Blood Clots

The risk of developing severe blood clots has been shown to be higher among men with prostate cancer compared to men of the same age without prostate cancer according to a study published in the online journal BMJ open.

Prostate cancer is a common cancer in middle-aged and older men. In general, people with cancer have a higher risk of developing a type of blood clot – venous thromboembolism (VTE) – dangerous but treatable blood clots in the veins.

“Men with prostate cancer appear to have a 50% higher risk of developing serious and potentially fatal blood clots during the five years.”

Prostate cancer and blood clots

VTE is known to be the most common cause of death among people with cancer, especially advanced diseases – two to three times higher in men with prostate cancer.

Although the risk is lower among prostate cancers compared to other cancers, the study encourages doctors to be draw attention to this risk in order to enable rapid diagnosis and treatment; if a blood clot occurs.

It was found that 3.2% of men in the prostate cancer group experienced VTE within about five years of being diagnosed with cancer, compared with 2.1% of men in the control group.

“The extent of the increased risk of VTE among men with prostate cancer seen in our study is lower than that seen for other cancers seen in previous studies, and is probably attributable to the high proportion of men with local disease and with a low risk of cancer. Nevertheless, physicians treating men with prostate cancer should be aware of the marked increase in VTE risk in these men, especially during the first six months after cancer diagnosis, to ensure a rapid diagnosis of VTE, the authors conclude.

Source: Medindia

Source link

Denial of responsibility! Tamilbloggers.xyz is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected] The content will be deleted within 24 hours.